The Centers for Disease Control and Prevention announced Monday that the U.S. is releasing vaccines that can prevent monkeypox from entering its national stockpile.
The Centers for Disease Control is in Atlanta.
According to the CDC, the Department of Health and Human Services has over 1,000 doses of Jynneos in its Strategic National Stockpile.
The U.S. had good stock of Jynneos in case of an outbreak of the disease.
The ACAM2000 vaccine can cause serious side effects, including heart inflammation, though the stockpile has over 100 million doses.
The FDA has not approved the use of the federal stockpile of smallpox antivirals to treat monkeypox, but they can be authorized for use under certain circumstances.
The first case of monkeypox in a human was identified in the Democratic Republic of Congo in 1970 and since then, the disease has become endemic in parts of western and central Africa. Up to 30 confirmed cases each in Portugal, Spain and the U.K. were reported in May, as well as up to five confirmed cases each in Canada and Australia. The first monkeypox case of the year was reported by the U.S. on Wednesday. At least six people are being monitored by the CDC for potential monkeypox infections after they were exposed to an individual with monkeypox during travel. Monkeypox can enter the body through broken skin, the respiratory tract and mucus membranes, and can also be spread through animal bites or scratches. The disease is usually mild and causes only a few symptoms, such as a throbbing head and a rash. According to the CDC, monkeypox can be fatal in 10% of cases in Africa.
Moderna is performing pre-clinical investigations of possible monkeypox vaccines.
There are new conspiracy theories about Bill Gates.
All Rights Reserved © 2024
